BioCentury
ARTICLE | Financial News

Aldagen amends IPO

July 5, 2010 7:00 AM UTC

Aldagen Inc., Durham, N.C. Business: Gene/Cell therapy Date announced: 7/2/10 Type: IPO To be raised: Up to $40 million Price: TBD Underwriter: Boenning & Scattergood Inc.; Ladenburg Thalmann; Nationa...